Patent Filing and Protection in India: A Complete Legal Guide for Inventors and Businesses

A patent grants its holder the exclusive right to prevent others from making, using, selling, or importing an invention in India for a period of 20 years from the date of filing. The Indian Patents Act, 1970, as amended, governs the grant and enforcement of patents in India and is administered by the Office of the Controller General of Patents, Designs and Trade Marks. India is a party to the Patent Cooperation Treaty, allowing applicants to file a single international application that extends protection to over 150 countries. For any business, researcher, or inventor with a novel product or process, understanding the patent filing process is essential to capturing and protecting the commercial value of innovation.

What Can and Cannot Be Patented in India

To be patentable in India, an invention must satisfy three conditions: it must be novel, meaning it has not been disclosed publicly anywhere in the world before the filing date; it must involve an inventive step, meaning it is not obvious to a person skilled in the relevant field; and it must be capable of industrial application. The Patents Act contains specific exclusions from patentability. Section 3 lists categories of subject matter that are not inventions and therefore cannot be patented. These include discoveries of laws of nature, mathematical methods, mental acts, methods of treatment of the human or animal body, plants and animals, traditional knowledge, and, critically for the pharmaceutical sector, Section 3(d) which prevents the grant of patents for new forms of known substances unless they demonstrate significantly enhanced efficacy. Section 3(k) excludes computer programmes per se and business methods, which affects software and fintech patent applications significantly.

The Filing Process: National and PCT Routes

A patent application in India can be filed directly at one of the four patent offices located in Chennai, Delhi, Kolkata, and Mumbai. The relevant office depends on the applicant's address. Applications can be filed as complete specifications or as provisional applications, where the provisional application reserves the filing date and allows the applicant 12 months to file the complete specification. A provisional application is useful where the invention is still being developed but the applicant wants to establish a priority date. For international protection, applicants can file a PCT application through the Indian Patent Office as a receiving office. A PCT application does not automatically grant a patent in any country but establishes an international filing date and begins the process of national phase entry in each country where protection is sought.

Examination, Opposition, and Grant

All patent applications in India must be examined by a patent examiner, but examination is not automatic. The applicant must file a Request for Examination within 48 months of the priority date or the date of filing. Failure to file the request within this period results in the application being deemed withdrawn. After examination, the Controller issues a First Examination Report setting out any objections. The applicant must respond to the FER within 6 months, extendable by a further 3 months, failing which the application lapses. Third parties can oppose a patent application before grant by filing a pre-grant opposition at any time before the grant. Post-grant opposition can also be filed within 12 months of the date of publication of the grant notice. The opposition process is a critical quality control mechanism and is actively used in the pharmaceutical sector to challenge questionable grants.

Working Requirement and Compulsory Licensing

India's patent law contains important provisions designed to ensure that patents are actually used to benefit Indian society. Every patentee and licensee is required to submit an annual statement to the Patent Office on Form 27 disclosing whether the patent has been worked commercially in India, the value of the product manufactured or imported, and the licences and sub-licences granted. Failure to file Form 27 attracts a fine. Where a patent is not being worked in India or is not available to the public at a reasonably affordable price, any person can apply to the Controller for a compulsory licence after three years from the date of grant. India's compulsory licensing provisions gained international attention in the Natco Pharma v. Bayer case, which established that these provisions can be used to override pharmaceutical patents for medicines that are not accessible to the Indian public at reasonable prices.

Practical Takeaways

Businesses and individual inventors with novel products or processes should conduct a prior art search before filing to assess patentability and freedom to operate. The 12-month provisional application window should be used where the invention is not yet fully documented but an early priority date is needed. All patent applicants should diarise the Request for Examination deadline and the FER response window, as missing either results in automatic lapse of the application. Companies with granted patents should ensure their annual Form 27 working disclosures are filed accurately and on time. Any company operating in markets where third parties hold relevant Indian patents should consider whether a freedom-to-operate analysis or a challenge to the patent through opposition proceedings is warranted.